These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2585617)

  • 41. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
    Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
    Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
    Pollack A; Zagars GZ
    Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.
    Pollack A; Zagars GK; Swanson DA
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):267-77. PubMed ID: 7928456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results of bladder-conserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter.
    Blank LE; Koedooder K; van Os R; van de Kar M; van der Veen JH; Koning CC
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):454-8. PubMed ID: 17560734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation therapy and cystectomy.
    Prout GR
    Urology; 1984 Apr; 23(4 Suppl):104-9. PubMed ID: 6710724
    [No Abstract]   [Full Text] [Related]  

  • 49. Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder.
    Konnak JW; Grossman HB
    Urology; 1985 Dec; 26(6):550-3. PubMed ID: 3934829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancer.
    Colquhoun AJ; Sundar S; Rajjayabun PH; Griffiths TR; Symonds RP; Mellon JK
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):702-9. PubMed ID: 17100158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bladder cancer: pattern of recurrence in 142 patients.
    Timmer PR; Hartlief HA; Hooijkaas JA
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):899-905. PubMed ID: 3988562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer.
    Tomic R; Granfors T; Modig H
    Scand J Urol Nephrol; 1997 Apr; 31(2):149-53. PubMed ID: 9165578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation therapy for transitional cell bladder carcinoma. A ten-year experience.
    Chougule P; Aygun C; Salazar O; Young J; Prempree T; Amin P
    Urology; 1988 Aug; 32(2):91-5. PubMed ID: 3135646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
    Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Full-dose irradiation for invasive bladder cancer: prognostic factors and techniques.
    Shipley WU
    Urology; 1984 Apr; 23(4 Suppl):95-100. PubMed ID: 6424299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.